TRAF6 and Src kinase activity regulates Cot activation by IL-1

Area of Science:

• Cellular signaling pathways
• Immunology
• Molecular biology

Background:

• Cot is a MAP kinase kinase kinase regulating the ERK1/ERK2 pathway.
• Cot activation by lipopolysaccharide (LPS) involves dissociation from NF-kappaB in macrophages.
• Interleukin-1 (IL-1) is a key cytokine in inflammatory responses.

Purpose of the Study:

• To investigate the role of Cot in IL-1-mediated signaling.
• To identify the specific MAP kinase kinase kinase activated by IL-1.
• To elucidate the downstream effects of IL-1-induced Cot activation on gene expression.

Main Methods:

• Measurement of endogenous Cot activity in response to IL-1.
• Analysis of IL-1-induced gene expression (IL-8, MIP-1beta) in cells with blocked Cot expression.
• Investigation of the involvement of TRAF6 and Src tyrosine kinases in IL-1 signaling.
• Use of PP1 inhibitor to assess the role of Src kinases.

Main Results:

• IL-1 induces a 10-fold increase in Cot activity, uniquely activating the ERK1/ERK2 pathway.
• Blocking Cot expression prevents IL-1-induced upregulation of IL-8 and MIP-1beta mRNA.
• IL-1-induced activation of the Cot-MKK1-ERK1/ERK2 pathway requires TRAF6.
• IL-1-mediated ERK1/ERK2 activation is inhibited by PP1, implicating Src tyrosine kinases, but not p38 or JNK activation.
• Src kinase inhibition does not affect IL-1-induced Cot dissociation, suggesting additional activation steps.

Conclusions:

• Cot is the sole MAP kinase kinase kinase responsible for IL-1-induced ERK1/ERK2 activation.
• The Cot-MKK1-ERK1/ERK2 pathway is essential for IL-1-mediated induction of specific inflammatory genes.
• IL-1 signaling to ERK1/ERK2 involves TRAF6 and Src tyrosine kinases, with post-dissociation events critical for Cot activation.